Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae

Pediatric Infectious Disease Journal

Volumn 18, Issue 7, 1999, Pages 638-646

  Ghaffar, Faryal ^a   Friedland, Ian R ^a,b   Mccracken Jr , George H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Nasopharyngeal colonization; Pneumococcal serotypes; Pneumococcal vaccines; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFIXIME; CEFPODOXIME; CEFPROZIL; PENICILLIN G; PNEUMOCOCCUS VACCINE; SULFAFURAZOLE;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BREAST FEEDING; CHILD; GEOGRAPHIC DISTRIBUTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; PATHOGENESIS; PENICILLIN RESISTANCE; PRIORITY JOURNAL; REVIEW; RHINOPHARYNGITIS; RISK FACTOR; SMOKING; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; HUMANS; INFANT; INFANT, NEWBORN; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032778893     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199907000-00016     Document Type: Review

References (100)

1. Andersson B, Eriksson B, Falsen E, et al. Adhesion of Streptococcus pneumoniae to human pharyngeal epithelial cells in vitro: differences in adhesive capacity among strains isolated from subjects with otitis media, septicemia, or meningitis or from healthy carriers. Infect Immun 1981;32: 311-7.
2. Andersson B, Beachey EH, Tomasz A, Tuomanen E, Svanborg-Eden C. A sandwich adhesion on Streptococcus pneumoniae attaching to human oropharyngeal epithelial cells in vitro. Microbial Pathog 1988;4:267-78.
3. Krivan HC, Roberts DD, Ginsburg V. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAcβ1-4Gal found in some glycolipids. Proc Natl Acad Sci USA 1988;85:6157-61.
4. Geelen S, Bhattacharyya C, Tuomanen E. The cell wall mediates pneumococcal attachment to and cytopathology in human endothelial cells. Infect Immun 1993;61:1538-43.
5. van der Flier M, Chhun N, Wizemann TM, Min J, McCarthy JB, Tuomanen EI. Adherence of Streptococcus pneumoniae to immobilized fibronectin. Infect Immun 1995;63:4317-22.
6. Weiser JN, Austrian R, Sreenivasan PK, Masure HR. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 1994;62:2582-9.
7. Kurono Y, Shigemi H. Inhibition of bacterial adherence by nasopharyngeal secretions. Ann Otol Rhinol Laryngol 1991; 100:455-8.
8. Virolainen A, Jero J, Käyhty H, et al. Nasopharyngeal antibodies to pneumococcal capsular polysaccharides in children with acute otitis media. J Infect Dis 1995;172:115-8.
9. Nieminen T, Virolainen A, Käyhty H, et al. Antibody-secreting cells and their relation to humoral antibodies in serum and in NP aspirates in children with pneumococcal AOM. J Infect Dis 1996;173:136-41.
10. Lindberg K, Freijd A, Rynnel-Dagoo B, Hammarström L. Anti pneumococcal antibody activity in nasopharyngeal secretions in healthy adults and children. Acta Otolaryngol (Stockh) 1993;113:673-8.
11. Gray BM, Converse GM III, Dillon HC Jr. Epidemiologic studies of the first 24 Streptococcus pneumoniae in infants: acquisition, carriage, and infection during months of life. J Infect Dis 1980;142:923-33.
12. Musher DM, Groover JE, Reichler MR, et al. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis 1997;24:441-6.
13. Gwaltney JM Jr, Sande MA, Austrian R, Hendley JO. Spread of Streptococcus pneumoniae in families: II Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis 1975;132:62-8.
14. Sanders E. Bacterial interference: I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci by viridans streptococci. J Infect Dis 120:698-707.
15. Johanson WG, Blackstock R, Pierce AK, Sanford JP. The role of bacterial antagonism in pneumococcal colonization of the human pharynx. J Lab Clin Med 1970;75:946-52.
16. Faden H, Stanievich J, Brodsky L, Bernstein J, Ogra PL. Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J 1990;9:623-6.
17. Hakansson A, Kidd A, Wadell G, Sabharwal H and Svanborg C. Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae Infect Immun 1994;62:2707-14.
18. Gray BM, Dillon HC Jr. Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis 1986;5:201-7.
19. Ekdahl K, Ahlinder I, Hansson HB, et al. Duration of NP carriage of PRP: experiences from the south Swedish pneumococcal intervention project. Clin Infect Dis 1997;25: 1113-7.
20. Steele RW, Warrier R, Unkel PJ, et al. Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease. J Pediatr 1996;128:531-5.
21. Ndoyo J, Siopathis RM, Klugman KP, et al. Center for Infectious Diseases, CDC. Antibiotic resistance among nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae: Bangui,1995. MMWR 1997;46:62-4.
22. Daw NC, Wilimas JA, Wang WC, et al. Nasopharyngeal carriage of disease, penicillin-resistant Streptococcus pneumoniae in children with sickle cell disease. Pediatrics 1997; 99:E7.
23. Appelbaum PC, Gladkova C, Hryniewicz W, et al. Carriage of antibiotic resistant Streptococcus pneumonias by children in Eastern and Central Europe. Clin Infect Dis 1996;23: 712-7.
24. Syrogiannopoulos GA, Grivea IN, Beratis NG, et al. Resistance patterns of Streptococcus pneumoniae from carriers attending day-care centers in Southwestern Greece. Clin Infect Dis 1997;25:188-94.
25. Yomo A, Subramanyan VR, Fudzulani R, et al. Carriage of penicillin-resistant pneumococci in Malawian children. Ann Trop Pediatr 1997;17:239-43.
26. Guillemot D, Boutou O, Carbon C, et al. Penicillin resistant Streptococcus pneumoniae carriage is strongly related to beta-lactam use [Abstract C-24]. Presented at the 38th Interscience Conference on Antimicrobial agents and Chemotherapy, San Diego, September 24 to 27, 1998. Washington, DC: American Society for Microbiology, 1998.
27. Ghaffar F, McCracken GH Jr, Friedland I. Effect of amoxicillin/clavulanate vs azithromycin on nasopharyngeal carriage and resistance of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media [Abstract C-30]. Presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 24 to 27, 1998. Washington, DC: American Society for Microbiology, 1998.
28. Belongia E, Sullivan B, Reed K, Chyou P, Vierkant R, Schwartz B. Risk factors for Penicillin-nonsusceptible Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae carriage in children attending day care [Abstract C-27]. Presented at the 38th Interscience Conference on Antimicrobial agents and Chemotherapy, San Diego, September 24 to 27, 1998. Washington, DC: American Society for Microbiology, 1998.
29. Sung RYT, Ling JM, Fung SM. Carriage of Haemophilus influenzae and Streptococcus pneumoniae in healthy Chinese and Vietnamese children in Hong Kong. Acta Paediatr 1995;84:1262-7.
30. Ussery XT, Gessner BD, Lipman H, et al. Risk of nasopharyngeal carriage of resistant Streptococcus pneumoniae and detection of a multiply resistant clone among children living in the Yukon-Kuskokwim Delta region of Alaska. Pediatr Infect Dis J 1996;15:986-92.
31. Yagupsky P, Porat N, Fraser D, et al. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in Southern Israel. J Infect Dis 1998;177:1003-12.
32. Hofman J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
33. Doern GV, Brueggemann A, Holley HP, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40: 1208-13.
34. Dagan R, Melamed R, Muallem M, Piglansky L, Yagupsky P. Nasopharyngeal colonization in Southern Israel with antibiotic-resistant pneumococci during the first two years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines. J Infect Dis 1996;174:1352-5.
35. Henderson FW, Gilligan PH, Wait K, Goff DA. Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis 1988;157:256-63.
36. Rosén C, Christensen P, Hovelius B, Prellner K. A longitudinal study of the nasopharyngeal carriage of pneumococci as related to pneumococcal vaccination in children attending day- care centers. Acta Otolaryngol (Stockh) 1984;98:524-32.
37. Rosen IA, Hakansson A, Aniansson G, et al. Antibodies to pneumococcal polysaccharides in human milk: lack of relationship to colonization and acute otitis media. Pediatr Infect Dis 1996;15:498-507.
38. Andersson B, Porras O, Hanson LÅ, Lagergård T, Svanborg-Edén C. Inhibition of attachment of Streptococcus pneumoniae and Haemophilus influenzae by human milk and receptor oligosaccharides. J Infect Dis 1986;153:232-7.
39. Kaleida PH, Nativio DG, Chao H, Cowden SN. Prevalence of bacterial respiratory pathogens in the nasopharynx in breast-fed versus formula-fed infants. J Clin Microbiol 1993; 31:2674-8.
40. Anainsson G., H. Sabharwal, C. Svanborg. Breast feeding and acute otitis media during the first year of life: a prospective study [Abstract 17]. Presented at the Fifth International Symposium on Recent Advances in Otitis Media, Fort Lauderdale, FL, May 20 to 24, 1991.
41. Duffy LC, Faden H, Wasielewski R, Wolf J, Krystofik D, Tonawanda/Williamsville Pediatrics. Exclusive breast feeding protects against bacterial colonization and day care exposure to otitis media. Pediatrics 1997;100:E7.
42. Gray BM, Turner ME, Dillon HC. Epidemiologic studies of Streptococcus pneumoniae in infants. Am J Epidemiol 1982; 116:692-703.
43. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995;14:745-50.
44. Schricker ME, Schreiber JR, Chiarucci K, et al. Absence of antibiotic-resistant Streptococcus pneumoniae pharyngeal colonization in Cleveland children with sickle cell disease. Pediatr Infect Dis J 1993;12:775-7.
45. Norris CF, Mahannah SR, Smith-Whitley K, Ohene-Frempong K, McGowan KL. Pneumococcal colonization in children with sickle cell disease. J Pediatr 1996;129:821-7.
46. Overturf GD, Field R, Lam C, Lee S, Powars DR. Nasopharyngeal carriage of pneumococci in children with sickle cell disease. Infect Immun 1980:1048-50.
47. Brook I, Gober AE. Prophylaxis with amoxicillin or sulfisoxazole for otitis media. Clin Infect Dis 1996;22:143-5.
48. Cohen R, Bingen E, Varon E, et al. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatr Infect Dis J 1997;16:555-60.
49. Dabernat H, Geslin P, Megraud F, et al. Effects of cefixime or co-amoxiclav treatment on NP carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with AOM. J Antimicrob Chemother 1998;41:253-8.
50. Leach AJ, Shelby-James TM, Mayo M, et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis 1997;24:356-62.
51. Brook I, Gober AE. Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media. J Antimicrob Chemother 1998;41:489-92.
52. Handwerger S, Tomasz A. Alterations in penicillin-binding proteins of clinical and laboratory isolates of pathogenic Streptococcus pneumoniae with low levels of penicillin resistance. J Infect Dis 1986;153:83-9.
53. Dagan R, Yagupsky P, Goldbart A, Wasaa A, Klugman K. Increasing prevalence of penicillin-resistant pneumococcal infections in children in Southern Israel: implications for future immunization policies. Pediatr Infect Dis J 1994;13: 782-6.
54. Guillemot D, Carbon C, Balkau B, et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998;279:365-70.
55. Sifaoui F, Kitzis MD, Gutmann L. In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral beta-lactam antibiotics is associated with alterations of PBP2x. Antimicrob Agents Chemother 1996; 40:152-6.
56. Carsenti-Etesse H, Durant J, De Salvador F, et al. In vitro development of resistance to beta-lactam antibiotics in Streptococcus pneumoniae. J Antimicrob Chemother 1995; 36:417-23.
57. Moreillon P, Tomasz A. Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment. J Infect Dis 1988;157:1150-7.
58. Garcia de Lomas J, Gimeno C, Bermejo M, et al. Antibiotic susceptibility of Streptococcus pneumoniae isolates from pediatric carriers in Spain. Eur J Clin Microbiol Infect Dis 1997;16:11-13.
59. Siboid C, Henrichsen J, Konig A, et al. Mosaic pbpx genes of major clones of penicillin-resistant Streptococcus pneumoniae have evolved from pbpx genes of a penicillin-sensitive Streptococcus oralis. Mol Microbiol 1994;12:1013-23.
60. Dowson CG, Coffey TJ, Kell C, Whiley RA. Evolution of penicillin resistance in Streptococcus pneumoniae: the role of Streptococcus mitis in the formation of a low affinity PBP2B in Streptococcus pneumoniae. Mol Microbiol 1993;9: 635-43.
61. Woods GM, Jorgensen JH, Waclawiw MA, et al. Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal Streptococcus pneumoniae among children with sickle cell anemia. J Pediatr Hematol Oncol 1997;19:327-33.
62. Anglin DL, Siegel JD, Pacini DL, et al. Effect of penicillin prophylaxis on nasopharyngeal colonization with Streptococcus pneumoniae in children with sickle cell anemia. J Pediatr 1984;104:18-22.
63. Krasinski K, Borkowsky W, Bonk S, Lawrence R, Chandwani S. Bacterial infections in HIV-infected children. Pediatr Infect Dis J 1988;7:323-8.
64. Bernstein LJ, Krieger BZ, Novick B, Sicklick MJ, Rubinstein A. Bacterial infections in the acquired immunodeficiency syndrome of children. Pediatr Infect Dis 1985;4: 472-5.
65. Rusen ID, Fraser-Roberts L, Slaney L, et al. Nasopharyngeal pneumococcal colonization among Kenyan children: antibiotic resistance, strain types and associations with human immunodeficiency virus type 1 infection. Pediatr Infect Dis J 1997;16:656-62.
66. Long SS, Henretig FM, Teter MJ, McGowen KL. Nasopharyngeal flora and acute otitis media. Infect Immun 1983;41: 987-91.
67. Zenni MK, Cheatam SH, Thompson JM, et al. Streptococcus pneumoniae colonization in the young child: association with OM and resistance to penicillin. J Pediatr 1995;127: 533-7.
68. Faden H, Duffy L, Wasielewski R, et al. Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis 1997;175:1440-5.
69. Leach AJ, Boswell JB, Asche V, Nienhuys TG, Mathews JD. Bacterial colonization of the NP predicts very early onset and persistence of otitis media in Australian Aboriginal infants. Pediatr Infect Dis 1994;13:983-9.
70. Finegold M, Klein J, Haslam GE, Tilles JG, Finland M, Gellis SS. Acute otitis media in children 1966;111:361-5.
71. Mortimer EA, Watterson RL. A bacteriologic investigation of otitis media in children. Pediatrics 1969;43:351-8.
72. Nilson BW, Poland RL, Thompson RS, Morehead D, Baghdassarian A, Carver DH. Acute otitis media: treatment results in relation to bacterial etiology. Pediatrics 1969;43: 351-8.
73. Gehanno P, Lenoir G, Barry B, Bons J, Boucot I, Berche P. Evaluation of nasopharyngeal cultures for bacteriologic assessment of acute otitis media in children. Pediatr Infect Dis J 1996;15:329-32.
74. Gudmundsson S, Erlendsdottir H, Thoroddsen E, et al. Nasal or nasopharyngeal cultures as predictors of etiology of acute maxillary sinusitis and acute otitis media. In: Proceedings of the 17th International Congress of Chemotherapy, Berlin, 1991.
75. Lehmann D, Gratten M, Montgomery J. Susceptibility of pneumococcal carriage isolates to penicillin provides a conservative estimate of susceptibility of invasive pneumococci. Pediatr Infect Dis J 1997;16:297-305.
76. Dagan R, Shriker O, Hazan I, et al. Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR. J Clin Microbiol 1998;36: 669-73.
77. Kellner JD, McGeer A, Cetron MS, et al. The use of Streptococcus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease. Pediatr Infect Dis J 1998;17:279-86.
78. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isoltes of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990;34:2075-80.
79. Mastro TD, Nomani NK, Ishaq Z, et al. Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J 1993;12:824-30.
80. Simoe AE, Louie M, The Canadian bacterial surveillance network, Low DE. Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1996; 40:2190-3.
81. Smith GM, Abbott KH. Development of experimental respiratory infections in neutropenic rats with either penicillin-resistant Streptococcus pneumoniae or beta-lactamase-producing Haemophilus influenzae. Antimicrob Agents Chemother 1994;38:608-10.
82. Azoulay-Dupuis E, Vallée E, Veber B, et al. In vivo efficacy of a new fluroquinolone, sparfloxacin, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrob Agents Chemother 1992;36:2698-703.
83. Smart LE, Platt DJ, Timbury MC. A comparison of the distribution of pneumococcal types in systemic disease and the upper respiratory tract in adults and children. Epidemiol Infect 1987;98:203-9.
84. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States,1978-1994: implications for the development of a conjugate vaccine. J Infect Dis 1995;171:885-9.
85. Mäkela PH, Sibakov M, Herva E, Henrichsen J. Pneumococcal vaccine and otitis media. Lancet 1980;2:547-51.
86. Riley ID, Lehmann D, Alpers M, Marshall TF, Gratten H, Smith D. Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children. Lancet 1986;2:877-81.
87. Herva E, Luotonen J, Timonen M, Sibakov M, Karma P, Mäkelä H. The effect of polyvalent pneumococcal polysaccharide vaccine on nasopharyngeal and nasal carriage of Streptococcus pneumoniae. Scand J Infect Dis 1980;12:97-100.
88. Klein JO. The epidemiology of pneumococcal disease in infants and children. Rev Infect Dis 1981;3:246-56.
89. Douglas RM, Paton JC, Duncan SJ, Hansman DJ. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 1983;148:131-7.
90. Åhman H, Käythy H, Tamminen P, Vuorela A, Malinoski F, Eskola J. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr Infect Dis J 1996;15: 134-9.
91. Black S, Shinefield H, Ray P, et al. (1) Kaiser Permanente Vaccine Study Center, Oakland, CA. (2) University of Pennsylvania, School of Medicine. (3) Wyeth Lederle Vaccines and Pediatrics Pearl River, NY [Abstract LB-9]. Presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 24 to 27, 1998. Washington, DC: American Society for Microbiology, 1998.
92. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 1996;174:1271-8.
93. Dagan R, Givon N, Yagupsky P, et al. Effect of a 9-valent pneumococcal vaccine conjugated to CRM 197 (PncCRM9) on nasopharyngeal carriage of vaccine type and non-vaccine type Streptococcus pneumoniae (Pnc) strains among day care center attendees(abstract G-52). Presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 24 to 27, 1998. Washington, DC: American Society for Microbiology, 1998.
94. Koornhoff HJ, Jacobs MR, Ward JI, Appelbaum PC, Hallet FA. Therapy and control of antibiotic-resistant pneumococcal disease. In: Schlessinger D, ed. Microbiology - 1979. Washington, DC: American Society for Microbiology, 1979: 286-9.
95. Klugman KP, Coffey TJ, Smith A, Wasas A, Meyers M, Spratt BG. Cluster of an erythromycin-resistant variant of the Spanish multiply resistant 23F clone of Streptococcus pneumoniae in South Africa. Eur J Clin Microbiol Infect 1994;13:171.
96. Kontiokari T, Uhari M, Koskela M. Antiadhesive effects of xylitol on otopathogenic bacteria. J Antimicob Agents Chemother 1998;41:563-5.
97. Kontiokari T, Uhari M, Koskela M. Effect of xylitol on growth of nasopharyngeal bacteria in vitro. Antimicrob Agents Chemother 1995;39:1820-3.
98. Uhari M, Kontiokari T, Koskela M, Niemelä M. Xylitol chewing gum in prevention of acute otitis media: double blind randomized trial. Br Med J 1996;313:1180-3.
99. Uhari M, Kontiokari T, Niemelä M. A novel use of xylitol sugar in preventing acute otitis media. Pediatrics 1998;102: 879-84.
100. Cundell D, Masure HR, Tuomanen EI. The molecular basis of pneumococcal infection: a hypothesis. Clin Infect Dis 1995;21:S204-12.